These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36644405)

  • 1. Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report.
    La Torre F; Calabrese G; Signorile K; Bizzoco F; Mastrorilli C; Strippoli A; Amato D; Carella F; Vairo U; Giordano P; Milella L; Cardinale F
    Front Pediatr; 2022; 10():1015617. PubMed ID: 36644405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.
    Çaǧlayan Ş; Sönmez HE; Otar Yener G; Baǧlan E; Öztürk K; Ulu K; Guliyeva V; Demirkol D; Çakan M; Özdel S; Bukulmez H; Aktay Ayaz N; Sözeri B
    Front Pediatr; 2022; 10():942455. PubMed ID: 36061383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
    Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
    JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity.
    Taddio A; Della Paolera S; Abbagnato L; Agrusti A; Badolato R; Biscaro F; Caorsi R; Consolaro A; Dellepiane RM; Fabi M; Floretta I; Gattorno M; Giangreco M; La Torre F; Maggio MC; Mambelli L; Mauro A; Mastrolia MV; Meneghel A; Montin D; Ricci F; Simonini G; Smarrazzo A; Sottile R; Stucchi S; Tardi M; Verdoni L; Zuccotti G; Zunica F; Ravelli A; Cattalini M;
    Rheumatology (Oxford); 2024 Feb; 63(2):366-375. PubMed ID: 37647645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous anakinra in the management of refractory MIS-C in France.
    Dusser P; Belot A; Bajolle F; Kevorkian-Verguet C; Meinzer U; Huet F; Tiriau S; Kone-Paut I
    Front Pediatr; 2024; 12():1270878. PubMed ID: 38464895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged Hospitalization in a Pediatric Patient With Multisystem Inflammatory Syndrome (MIS-C) and Human Rhino-Enterovirus Infection: A Case Report.
    Lee ASE; Stojkic I; Ogbu EA
    Cureus; 2022 Sep; 14(9):e29380. PubMed ID: 36304349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center.
    Sözeri B; Çağlayan Ş; Atasayan V; Ulu K; Coşkuner T; Pelin Akbay Ö; Hasbal Akkuş C; Atay G; Salı E; Karacan M; Öner T; Erdoğan S; Demir F
    Postgrad Med; 2021 Nov; 133(8):994-1000. PubMed ID: 34605352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children.
    Katlan B; Kesici S; Karacanoğlu D; Oygar PD; Ünal Yüksekgönül A; Şener S; Aykan HH; Özsurekçi Y; Özen S; Bayrakci B
    J Clin Apher; 2022 Jun; 37(3):281-291. PubMed ID: 35174897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children.
    Chang JC; Young CC; Muscal E; Sexson Tejtel SK; Newhams MM; Kucukak S; Crandall H; Maddux AB; Rowan CM; Halasa NB; Harvey HA; Hobbs CV; Hall MW; Kong M; Aguiar CL; Schuster JE; Fitzgerald JC; Singh AR; Wellnitz K; Nofziger RA; Cvijanovich NZ; Mack EH; Schwarz AJ; Heidemann SM; Newburger JW; Zambrano LD; Campbell AP; Patel MM; Randolph AG; Son MBF;
    Arthritis Rheumatol; 2023 Aug; 75(8):1466-1476. PubMed ID: 36908050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
    Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
    Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study.
    Licciardi F; Covizzi C; Dellepiane M; Olivini N; Mastrolia MV; Lo Vecchio A; Monno V; Tardi M; Mauro A; Alessio M; Filocamo G; Cattalini M; Taddio A; Caorsi R; Marseglia GL; La Torre F; Campana A; Simonini G; Ravelli A; Montin D
    Front Pediatr; 2023; 11():1137051. PubMed ID: 37675397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.
    Tolunay O; Çelik Ü; Arslan İ; Orgun A; Demir H; Demir O; Dağdelen EÇ
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Study of Children with MIS-C between Admitted to the Pediatric Intensive Care Unit and Pediatric Ward: A One-Year Retrospective Study.
    Kıymet E; Böncüoğlu E; Şahinkaya Ş; Cem E; Çelebi MY; Düzgöl M; Kara AA; Arıkan KÖ; Vuran GT; Yılmazer MM; Sandal ÖS; Ağın H; Pirinç N; Bayram N; Devrim İ
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34931251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
    Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A
    J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis.
    Hasan H; Hysko K; Jack T; Dingemann J; Wetzke M; Hansmann G
    Front Cardiovasc Med; 2022; 9():984698. PubMed ID: 36568561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 7-Year-Old Boy and a 14-Year-Old Girl Initially Diagnosed with Toxic Shock Syndrome and Tested Positive for SARS-CoV-2 Infection, Supporting a Diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C).
    Giordano S; Failla MC; Li Cavoli MG; Romano D; Vanella V; Caruso C; Chillura I; Maggio MC
    Am J Case Rep; 2021 Oct; 22():e931570. PubMed ID: 34635631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.